ICCC: ImmuCell Corporation Enterprise Value to EBITDA Ratio

ImmuCell Corporation (ICCC) develops livestock health maintenance products and ensures stable agrologistics through its network of US plants, confirming a market trend visualized in monetary terms with a value of 22.80. The business relies on the implementation of innovative methods to protect calves from diseases without the use of antibiotics. Strict control over vaccine distribution and diversified raw material imports allow the company to seamlessly supply farms with the necessary preparations.

ICCC ImmuCell Corp: Business Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/12/2026

immucell.com (ICCC) - metric breakdowns and financial figures

- stock price and consensus target price:

Stock Quotes ImmuCell Corp.|ICCC - Analyst Forecast Prices

- market capitalization information:

Market Valuation ImmuCell Corporation Inc|ICCC - Enterprise Value

- business book valuation details:

Net Assets per Single Share ImmuCell|ICCC - Accounting Value of Company|Market Capitalization to Book Value Ratio immucell.com|ICCC - Company Total Assets

- issuer credit burden and liquidity indicators:

- business earnings and investment ratios data:

ICCC - Net Financial Result|Expected Profit ImmuCell Corporation|ICCC - Market Cap to Earnings|Projected Price to Earnings ImmuCell Corporation|ICCC - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImmuCell Corporation Inc|ICCC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ImmuCell|ICCC - Net earnings per share for the last 12 months|Quarterly EPS earnings growth immucell.com|ICCC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year ImmuCell Corporation

Summary company analysis:ICCC (ImmuCell Corp.)

ImmuCell Corporation (ICCC) maintains an impeccable reputation in livestock immunity protection, and the brand trust associated with FirstDefense generates a steady cash flow that underpins the calculation of operating profit. The company's dynamic EV/EBITDA ratio compares the total enterprise value with this profit before taxes and depreciation, allowing investors to determine the premium paid for the asset and assess the balance of market demand.

Key competitors

Corteva Inc - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NTR (Nutrien Corp)|CF: Enterprise Value to EBITDA Ratio|MOS - EV/EBITDA Multiple|Elanco (ELAN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Balchem Corp - Business Value to Operating Income Before Depreciation|FMC (FMC Corp.) - EV/EBITDA Multiple|EV/EBITDA Multiple scottsmiraclegro.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Phibro Animal Health (PAHC)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization UAN (cvrpartners.com)|Oil-Dri Corp of America - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IPI|LVRO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation AVD (American Vanguard)|GRO: EV/EBITDA Multiple|Company Value to EBITDA cgagri.com (ENFY)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Origin Agritech Ltd.|China Green Agriculture Inc. (CGA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization S&W Seed Company, Inc. (SANW)